# BIOMARIN PHARMACEUTICAL INC
> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.
## Record
| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/biomarin-pharmaceutical-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 35 |
| Claims under review | 1 |
| Evidence records | 13 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-16T14:33:03.798+00:00 |
| Last reviewed | 2026-10-16T14:33:03.798+00:00 |
## Identity
- Legal name: BIOMARIN PHARMACEUTICAL INC
- Display name: BIOMARIN PHARMACEUTICAL INC
## Alpha Governance Record
| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-17T04:30:13.933333+00:00 |
| Completeness | 0.409 |
| Record Quality | 0.838 |
| Directors | 10 |
| Committees | 6 |
| Governance events | 25 |
| Entity class | public_company |
## Section coverage
| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | PUBLISHED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |
## Board
- Adrian Hardy: Director. Status: current. Independent: false. Since: 2023-01-01. claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:6
- Athena Countouriotis: Director. Status: current. Independent: true. Since: 2023-01-01. claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:7
- Barbara W. Bodem: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Audit (member). claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:8
- Elizabeth McKee Anderson: Director. Status: current. Independent: true. Since: 2019-01-01. Committees: Compensation (chair); Compensation · Chair (member). claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:9
- Ian T. Clark: Director. Status: current. Independent: true. Since: 2025-01-01. claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:10
- Mark Enyedy: Director. Status: current. Independent: true. Since: 2023-01-01. claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:11
- Maykin Ho: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Audit (member). claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:12
- Robert J. Hombach: Director. Status: current. Independent: true. Since: 2017-01-01. Committees: Audit (chair); Audit · Chair (member). claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:13
- Timothy P. Walbert: Director. Status: current. Independent: true. Since: 2025-01-01. Committees: Compensation (member); Compensation; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:14
- Willard Dere: Director. Status: current. Independent: true. Since: 2016-01-01. Committees: Nominating and Governance (member). claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:15
## Committees
- Audit (audit). Chair: Robert J. Hombach. Members: Robert J. Hombach (chair, current); Barbara W. Bodem (member, current); Maykin Ho (member, current). committee_id=alpha:committee:biomarin-pharmaceutical-inc:audit
- Audit · Chair (audit). Chair: NOT_PUBLISHED. Members: Robert J. Hombach (member, current). committee_id=alpha:committee:biomarin-pharmaceutical-inc:audit-chair
- Compensation (compensation). Chair: Elizabeth McKee Anderson. Members: Elizabeth McKee Anderson (chair, current); Timothy P. Walbert (member, current). committee_id=alpha:committee:biomarin-pharmaceutical-inc:compensation
- Compensation · Chair (compensation). Chair: NOT_PUBLISHED. Members: Elizabeth McKee Anderson (member, current). committee_id=alpha:committee:biomarin-pharmaceutical-inc:compensation-chair
- Compensation; Nominating and Governance (compensation). Chair: NOT_PUBLISHED. Members: Timothy P. Walbert (member, current). committee_id=alpha:committee:biomarin-pharmaceutical-inc:compensation-nominating-and-governance
- Nominating and Governance (nominating_governance). Chair: NOT_PUBLISHED. Members: Timothy P. Walbert (member, current); Willard Dere (member, current). committee_id=alpha:committee:biomarin-pharmaceutical-inc:nominating-and-governance
## Executive leadership
- Adrian Hardy: President and Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:16
- Alexander Hardy: President and Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:17
- Brian R. Mueller: Executive Vice President and Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:18
- C. Greg Guyer: Executive Vice President and Chief Technical Officer. Status: current. claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:19
- Cristin Hubbard: Executive Vice President and Chief Commercial Officer. Status: current. claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:20
- George S. Davis: Executive Vice President, Chief Legal Officer and Secretary [GC]. Status: current. claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:23
- Gregory R. Friberg: Executive Vice President and Chief Research Development Officer. Status: current. claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:24
- Rashmi Ramchandani: Vice President and Chief Accounting Officer [CAO]. Status: current. claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:25
- Erin Burkhart: Group Vice President and Chief Accounting Officer [CAO]. Status: unknown. claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:21
- G. Eric Davis: Executive Vice President, Chief Legal Officer and Secretary [GC]. Status: unknown. claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:22
## Governance events
- CEO_CHANGED: Adrian Hardy executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-16T14:33:03.798+00:00. event_id=alpha:event:transition:10bsjzq13o4ih0
- CEO_CHANGED: Alexander Hardy executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-16T14:33:03.798+00:00. event_id=alpha:event:transition:9f1wel1o9vnht
- CFO_CHANGED: Brian R. Mueller executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-16T14:33:03.798+00:00. event_id=alpha:event:transition:xdm6ip16e42u9
- EXECUTIVE_APPOINTED: C. Greg Guyer executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-16T14:33:03.798+00:00. event_id=alpha:event:transition:1e3v2prequzfb
- EXECUTIVE_APPOINTED: Cristin Hubbard executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-16T14:33:03.798+00:00. event_id=alpha:event:transition:qg9vqgzrrthu
- GC_CHANGED: George S. Davis executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-16T14:33:03.798+00:00. event_id=alpha:event:transition:1x57yp41tmi562
- EXECUTIVE_APPOINTED: Gregory R. Friberg executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-16T14:33:03.798+00:00. event_id=alpha:event:transition:67rpxmwmies8
- EXECUTIVE_APPOINTED: Rashmi Ramchandani executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-16T14:33:03.798+00:00. event_id=alpha:event:transition:yom8pw1xd3fru
- DIRECTOR_APPOINTED: Ian T. Clark seat on BIOMARIN PHARMACEUTICAL INC, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T14:33:03.798+00:00. event_id=alpha:event:transition:slmkwn8jbhyt
- DIRECTOR_APPOINTED: Timothy P. Walbert seat on BIOMARIN PHARMACEUTICAL INC, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T14:33:03.798+00:00. event_id=alpha:event:transition:ysoj9fnvv9x5
- COMMITTEE_CREATED: Compensation; Nominating and Governance committee of BIOMARIN PHARMACEUTICAL INC, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T14:33:03.798+00:00. event_id=alpha:event:transition:1c7a4hbrcap0p
- COMMITTEE_MEMBER_ADDED: Timothy P. Walbert member of Compensation; Nominating and Governance, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T14:33:03.798+00:00. event_id=alpha:event:transition:1eoccuv19hibqf
- DIRECTOR_APPOINTED: Adrian Hardy seat on BIOMARIN PHARMACEUTICAL INC, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T14:33:03.798+00:00. event_id=alpha:event:transition:1ytbvx6ylibus
- DIRECTOR_APPOINTED: Athena Countouriotis seat on BIOMARIN PHARMACEUTICAL INC, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T14:33:03.798+00:00. event_id=alpha:event:transition:1ckheej16luhfp
- DIRECTOR_APPOINTED: Barbara W. Bodem seat on BIOMARIN PHARMACEUTICAL INC, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T14:33:03.798+00:00. event_id=alpha:event:transition:12gcmygwmc522
- DIRECTOR_APPOINTED: Mark Enyedy seat on BIOMARIN PHARMACEUTICAL INC, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T14:33:03.798+00:00. event_id=alpha:event:transition:1k7gye81y4ax6
- COMMITTEE_MEMBER_ADDED: Barbara W. Bodem member of Audit, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T14:33:03.798+00:00. event_id=alpha:event:transition:ioeli1bvnh7v
- DIRECTOR_APPOINTED: Maykin Ho seat on BIOMARIN PHARMACEUTICAL INC, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T14:33:03.798+00:00. event_id=alpha:event:transition:17z0sfp1hd8vej
- DIRECTOR_APPOINTED: Elizabeth McKee Anderson seat on BIOMARIN PHARMACEUTICAL INC, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T14:33:03.798+00:00. event_id=alpha:event:transition:1kx7qpq1d1huza
- COMMITTEE_CREATED: Compensation · Chair committee of BIOMARIN PHARMACEUTICAL INC, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T14:33:03.798+00:00. event_id=alpha:event:transition:hlb9wm2v5o9y
- COMMITTEE_MEMBER_ADDED: Elizabeth McKee Anderson member of Compensation · Chair, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T14:33:03.798+00:00. event_id=alpha:event:transition:nhxmic1308wiq
- DIRECTOR_APPOINTED: Robert J. Hombach seat on BIOMARIN PHARMACEUTICAL INC, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T14:33:03.798+00:00. event_id=alpha:event:transition:3u9xmj1rebxvn
- COMMITTEE_CREATED: Audit · Chair committee of BIOMARIN PHARMACEUTICAL INC, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T14:33:03.798+00:00. event_id=alpha:event:transition:15daymd6mkw47
- COMMITTEE_MEMBER_ADDED: Robert J. Hombach member of Audit · Chair, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T14:33:03.798+00:00. event_id=alpha:event:transition:b1zd9q1lw987m
- DIRECTOR_APPOINTED: Willard Dere seat on BIOMARIN PHARMACEUTICAL INC, effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-16T14:33:03.798+00:00. event_id=alpha:event:transition:1z0frgsxsnv38
## Scoped resources
- `alpha://company/biomarin-pharmaceutical-inc` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record
- `alpha://company/biomarin-pharmaceutical-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=identity
- `alpha://company/biomarin-pharmaceutical-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=corporate-structure
- `alpha://company/biomarin-pharmaceutical-inc/board` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=board
- `alpha://company/biomarin-pharmaceutical-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=committees
- `alpha://company/biomarin-pharmaceutical-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=leadership
- `alpha://company/biomarin-pharmaceutical-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=ownership
- `alpha://company/biomarin-pharmaceutical-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=financials
- `alpha://company/biomarin-pharmaceutical-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=capital-structure
- `alpha://company/biomarin-pharmaceutical-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=compensation
- `alpha://company/biomarin-pharmaceutical-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=governance
- `alpha://company/biomarin-pharmaceutical-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=shareholder-governance
- `alpha://company/biomarin-pharmaceutical-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=audit
- `alpha://company/biomarin-pharmaceutical-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=legal
- `alpha://company/biomarin-pharmaceutical-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=risk
- `alpha://company/biomarin-pharmaceutical-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=cyber
- `alpha://company/biomarin-pharmaceutical-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=ai-governance
- `alpha://company/biomarin-pharmaceutical-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=agents
- `alpha://company/biomarin-pharmaceutical-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=ecosystem
- `alpha://company/biomarin-pharmaceutical-inc/events` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=events
- `alpha://company/biomarin-pharmaceutical-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=relationships
- `alpha://company/biomarin-pharmaceutical-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=assessments
- `alpha://company/biomarin-pharmaceutical-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=evidence
## Role modules
- NOT_ASSERTED
## Attention
- NO_RECORDS_FOUND
## Committee data
- Claim alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_appointment:27: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:robert-j-hombach","name":"Robert J. Hombach"},"source_id":"board_seats"}`
- Claim alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_appointment:28: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:barbara-w-bodem","name":"Barbara W. Bodem"},"source_id":"board_seats"}`
- Claim alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_appointment:29: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:maykin-ho","name":"Maykin Ho"},"source_id":"board_seats"}`
- Claim alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_appointment:31: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:elizabeth-mckee-anderson","name":"Elizabeth McKee Anderson"},"source_id":"board_seats"}`
- Claim alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_appointment:32: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:timothy-p-walbert","name":"Timothy P. Walbert"},"source_id":"board_seats"}`
- Claim alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_appointment:34: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:timothy-p-walbert","name":"Timothy P. Walbert"},"source_id":"board_seats"}`
- Claim alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_appointment:35: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:willard-dere","name":"Willard Dere"},"source_id":"board_seats"}`
## Leadership
- Adrian Hardy: Director. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:6. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b.
- Athena Countouriotis: Director. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:7. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b.
- Barbara W. Bodem: Director, Audit. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:8. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b.
- Elizabeth McKee Anderson: Director, Compensation · Chair. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:9. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b.
- Ian T. Clark: Director. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:10. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b.
- Mark Enyedy: Director. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:11. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b.
- Maykin Ho: Director, Audit. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:12. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b.
- Robert J. Hombach: Director, Audit · Chair. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:13. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b.
- Timothy P. Walbert: Director, Compensation; Nominating and Governance. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:14. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b.
- Willard Dere: Director, Nominating and Governance. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:15. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b.
- Adrian Hardy: President and Chief Executive Officer. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:16. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b3598f3e6eda560d83a00f9929a83cc61bd68f09f96aa5c37d826e06902d6ccf.
- Alexander Hardy: President and Chief Executive Officer. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:17. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b9594a4aa6be439b3adb396114e1a37caa813bbc904fc7cc39b1525322583957.
- Brian R. Mueller: Executive Vice President and Chief Financial Officer. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:18. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5f45c97dfae6a6e2383333577db0ddd9d1ab8eb5c78790fcf2c65bed5b404c65.
- C. Greg Guyer: Executive Vice President and Chief Technical Officer. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:19. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:890d97ecd15c01311b5a4638e3242135244cb3d73e8b2179e02cd23655b0dc3c.
- Cristin Hubbard: Executive Vice President and Chief Commercial Officer. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:20. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c94a9faf9269f87822325409f687ec8adbfc598b242875c9b808dadd22801e37.
- Erin Burkhart: Group Vice President and Chief Accounting Officer. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8ffe27fdac74e43ddbcafe3b2e4b48e3a87aa42cab0a7e79498d4b4f906a3897.
- G. Eric Davis: Executive Vice President, Chief Legal Officer and Secretary. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:624c60829bef719a7ff8952f6d4812bb95faf233edf1304455c3675f1b7f0e91.
- George S. Davis: Executive Vice President, Chief Legal Officer and Secretary. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:23. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3121c99406bd9128465de8ae6050939c26d7b39a2c5e0f37dff1514f939af504.
- Gregory R. Friberg: Executive Vice President and Chief Research Development Officer. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:24. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9b441dcc83b81cd5ab5d3f3cd2140e086e130c56013ce7d559e22b12e9cc046c.
- Rashmi Ramchandani: Vice President and Chief Accounting Officer. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:25. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a6d83333796563896596434ce13073426eff92b856543f6f9e372e576373949f.
## Roles
- PUBLISHED
## Governance
- NOT_ASSERTED
## Board committees
- Audit: Chair Robert J. Hombach; Members Robert J. Hombach (Chair); Barbara W. Bodem; Maykin Ho. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_record:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a25b8e211eed7ea4b80085339941077ce8f3de1a7202bf571657a7b39f2545fa.
- Compensation: Chair Elizabeth McKee Anderson; Members Elizabeth McKee Anderson (Chair); Timothy P. Walbert. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_record:30. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a25b8e211eed7ea4b80085339941077ce8f3de1a7202bf571657a7b39f2545fa.
- Nominating and Governance: Chair not stated; Members Timothy P. Walbert; Willard Dere. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_record:33. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a25b8e211eed7ea4b80085339941077ce8f3de1a7202bf571657a7b39f2545fa.
## Financials
- NOT_ASSERTED
## Workforce
- NOT_ASSERTED
## Market and index context
- PUBLISHED
## Legal Name
- BIOMARIN PHARMACEUTICAL INC. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:52eaaade9c8cb409e5b2c5bb3d5f3e9e5a159f7257317cec85c485a20a910d15.
## Entity Status
- Public listing published. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:52eaaade9c8cb409e5b2c5bb3d5f3e9e5a159f7257317cec85c485a20a910d15.
## Published Fact
- US. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:52eaaade9c8cb409e5b2c5bb3d5f3e9e5a159f7257317cec85c485a20a910d15.
- Healthcare. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:52eaaade9c8cb409e5b2c5bb3d5f3e9e5a159f7257317cec85c485a20a910d15.
## Committee Appointment
- Robert J. Hombach: chair, Audit. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a25b8e211eed7ea4b80085339941077ce8f3de1a7202bf571657a7b39f2545fa.
- Barbara W. Bodem: member, Audit. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_appointment:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a25b8e211eed7ea4b80085339941077ce8f3de1a7202bf571657a7b39f2545fa.
- Maykin Ho: member, Audit. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_appointment:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a25b8e211eed7ea4b80085339941077ce8f3de1a7202bf571657a7b39f2545fa.
- Elizabeth McKee Anderson: chair, Compensation. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_appointment:31. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a25b8e211eed7ea4b80085339941077ce8f3de1a7202bf571657a7b39f2545fa.
- Timothy P. Walbert: member, Compensation. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_appointment:32. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a25b8e211eed7ea4b80085339941077ce8f3de1a7202bf571657a7b39f2545fa.
- Timothy P. Walbert: member, Nominating and Governance. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_appointment:34. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a25b8e211eed7ea4b80085339941077ce8f3de1a7202bf571657a7b39f2545fa.
- Willard Dere: member, Nominating and Governance. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_appointment:35. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a25b8e211eed7ea4b80085339941077ce8f3de1a7202bf571657a7b39f2545fa.
## Security Listing
- BMRN (NASDAQ). Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:security_listing:36. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:52eaaade9c8cb409e5b2c5bb3d5f3e9e5a159f7257317cec85c485a20a910d15.
## Coverage states
| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |
## Public sources
- alpha:projection-evidence:52eaaade9c8cb409e5b2c5bb3d5f3e9e5a159f7257317cec85c485a20a910d15: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc).
- alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b: [BioMarin Pharmaceutical DEF 14A 2026-04-21](https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm).
- alpha:projection-evidence:document:b3598f3e6eda560d83a00f9929a83cc61bd68f09f96aa5c37d826e06902d6ccf: [BMRN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm).
- alpha:projection-evidence:document:b9594a4aa6be439b3adb396114e1a37caa813bbc904fc7cc39b1525322583957: [BMRN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm).
- alpha:projection-evidence:document:5f45c97dfae6a6e2383333577db0ddd9d1ab8eb5c78790fcf2c65bed5b404c65: [BMRN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm).
- alpha:projection-evidence:document:890d97ecd15c01311b5a4638e3242135244cb3d73e8b2179e02cd23655b0dc3c: [BMRN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm).
- alpha:projection-evidence:document:c94a9faf9269f87822325409f687ec8adbfc598b242875c9b808dadd22801e37: [BMRN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm).
- alpha:projection-evidence:document:8ffe27fdac74e43ddbcafe3b2e4b48e3a87aa42cab0a7e79498d4b4f906a3897: BMRN executive roster source.
- alpha:projection-evidence:document:624c60829bef719a7ff8952f6d4812bb95faf233edf1304455c3675f1b7f0e91: BMRN executive roster source.
- alpha:projection-evidence:document:3121c99406bd9128465de8ae6050939c26d7b39a2c5e0f37dff1514f939af504: [BMRN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm).
- alpha:projection-evidence:document:9b441dcc83b81cd5ab5d3f3cd2140e086e130c56013ce7d559e22b12e9cc046c: [BMRN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm).
- alpha:projection-evidence:document:a6d83333796563896596434ce13073426eff92b856543f6f9e372e576373949f: [BMRN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm).
- alpha:projection-evidence:a25b8e211eed7ea4b80085339941077ce8f3de1a7202bf571657a7b39f2545fa: [Audit](https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm).
## Rights
| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |
## Limitations
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
## Alternate representations
- [Canonical profile](https://registry.alpha.ac/companies/biomarin-pharmaceutical-inc)
- [Public Markdown](https://registry.alpha.ac/companies/biomarin-pharmaceutical-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=jsonld)
- MCP resource: `alpha://companies/biomarin-pharmaceutical-inc` at https://mcp.alpha.ac/mcp
## Connected governance records
Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.
## Critical-risk oversight
Snapshot as of 2026-10-17T04:30:13.429265+00:00; recorded 2026-10-17T04:30:13.429265+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.BIOMARIN PHARMACEUTICAL INC, for agents
The same record as the human view, as a structured object any agent can read and cite. Reading is open to every agent, model, and tool, with no key and no account. Signing and transparency logging are not yet published for this record.
- Alpha ID
- alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8
- Version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ceRecorded Oct 16, 2026
- Content hash
- Not yet signed
- Signature
- Not yet signed
- Transparency log
- Not yet signed
- Freshness
- ObservedChecked Oct 16, 2026. Reviewed Oct 16, 2026
- Read access
- OpenNo key for public retrieval
- Processing basis
- Public recordDoctrine
Read
OpenOne canonical URL. The Accept header or a file suffix selects the format. Every format renders the same Claims and carries the same record version.
curl -H "Accept: application/json" https://registry.alpha.ac/companies/biomarin-pharmaceutical-incTrustCheck and Governance Receipts
Agent tierIllustrative. TrustChecks run in the private enterprise overlay. The example below is generated for this entity class and does not reference this record. Contract: TrustCheck and Governance Receipts v0.1.
Agents about to act ask a question, not for a document. A TrustCheck evaluates the AuthorityGrant objects behind a proposed action and returns allow, deny, require_approval, or insufficient_evidence. The source system acts, and a GovernanceReceipt records what the agent relied on.
- allow, deny
- The AuthorityGrant and policy decide. Reason codes name the rule.
- require_approval
- An entitled human records the decision. Customer policy sets the threshold, never an Eval.
- insufficient_evidence
- No authority is registered. Alpha never infers permission to act.
curl https://www.alpha.ac/v1/action-intents \
-H 'Content-Type: application/json' \
-b "$ALPHA_SESSION_COOKIE" \
-d '{
"schema_version": "2026-08-29",
"environment": "test",
"actor": { "alpha_id": "alpha:account:self", "type": "alpha_account" },
"principal": { "alpha_id": "alpha:company:example-issuer", "type": "organization" },
"organization": { "alpha_id": "alpha:company:example-issuer", "type": "organization" },
"proposed_action": { "type": "purchase_order.commit", "description": "Accept an order placed by an agent claiming company authority." },
"requested_authority": ["purchase_order.commit"]
}'
# then
curl https://www.alpha.ac/v1/trust-checks -H 'Content-Type: application/json' \
-b "$ALPHA_SESSION_COOKIE" -d '{ "action_intent_id": "<from the previous response>" }'{
"schema_version": "2026-08-29",
"trust_check_id": "alpha:trust-check:illustrative-0001",
"decision": "insufficient_evidence",
"explanation": "No AuthorityGrant names this agent and organization.",
"reason_codes": [
"authority_grant_missing"
],
"evaluated_authority": {
"authority_grants": []
},
"policy_version": "trustcheck.registry-claim.test.v0.1",
"integrity_state": "recorded",
"limitations": [
"Illustrative example. No TrustCheck was run for this record."
]
}{
"schema_version": "2026-08-29",
"receipt_id": "alpha:receipt:illustrative-0001",
"environment": "test",
"actor": {
"alpha_id": "alpha:account:self",
"type": "alpha_account"
},
"agent": {
"provider": {
"alpha_id": "alpha:company:example-agent-provider",
"type": "provider"
},
"product": {
"alpha_id": "alpha:agent-product:example-procurement-agent",
"type": "agent_product"
},
"deployment": {
"alpha_id": "alpha:agent-deployment:example-deployment",
"type": "agent_deployment"
},
"use_case": {
"alpha_id": "alpha:agent-use-case:example-purchase-order",
"type": "agent_use_case"
},
"workflow": "Illustrative purchase order commitment"
},
"principal": {
"alpha_id": "alpha:company:example-issuer",
"type": "organization"
},
"sponsor": {
"alpha_id": "alpha:company:example-issuer",
"type": "organization"
},
"action_intent_id": "alpha:action-intent:illustrative-0001",
"trust_check_id": "alpha:trust-check:illustrative-0001",
"authority_grant_references": [],
"action_intent": {
"type": "purchase_order.commit"
},
"affected_alpha_ids": [
"alpha:company:example-issuer"
],
"trust_check_decision": "insufficient_evidence",
"policy_version": "trustcheck.registry-claim.test.v0.1",
"rule_references": [
{
"reason_code": "authority_grant_missing",
"rule_id": "trustcheck.authority_grant_missing",
"policy_ref": "trustcheck.registry-claim.test.v0.1",
"control_ref": null,
"grant_policy_references": []
}
],
"integrity": "Illustrative. Not issued, not signed."
}Connect
Open readEvery surface reads the same published record. No surface holds its own copy of the facts.
// claude_desktop_config.json, Cursor, or any MCP client
{
"mcpServers": {
"alpha": { "url": "https://mcp.alpha.ac/mcp" }
}
}
// This record as an MCP resource
alpha://companies/biomarin-pharmaceutical-incalpha://companies/biomarin-pharmaceutical-incThis record as an MCP resourcehttps://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=recordThe same record over HTTP
Subscribe to changes
Agent tier, previewNo public subscription endpoint is published yet. Event delivery is part of Agent tier access, in preview. Access and availability.
CEO_CHANGEDDerived governance event published on this record (alpha-governance-event-derivation-v2)CFO_CHANGEDDerived governance event published on this record (alpha-governance-event-derivation-v2)EXECUTIVE_APPOINTEDDerived governance event published on this record (alpha-governance-event-derivation-v2)GC_CHANGEDDerived governance event published on this record (alpha-governance-event-derivation-v2)DIRECTOR_APPOINTEDDerived governance event published on this record (alpha-governance-event-derivation-v2)COMMITTEE_CREATEDDerived governance event published on this record (alpha-governance-event-derivation-v2)COMMITTEE_MEMBER_ADDEDDerived governance event published on this record (alpha-governance-event-derivation-v2)
{
"specversion": "1.0",
"type": "ac.alpha.registry.CEO_CHANGED",
"source": "https://registry.alpha.ac/companies/biomarin-pharmaceutical-inc",
"subject": "alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8",
"data": {
"record_version": "public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce",
"note": "Subscription delivery is Agent tier, preview. Not yet available publicly."
}
}Versions and changes
OpenRecords are versioned. Derived governance events on this record are listed below with the version that publishes them. Effective is the world time the derivation states; Recorded is when Alpha detected the event. Content hashes and log entries appear once records are signed.
| Version | Effective | Recorded | Content hash | Log entry | What changed |
|---|---|---|---|---|---|
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Apr 21, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Adrian Hardy executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Apr 21, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Alexander Hardy executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Apr 21, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Brian R. Mueller executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Apr 21, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | C. Greg Guyer executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Apr 21, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Cristin Hubbard executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Apr 21, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | George S. Davis executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Apr 21, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Gregory R. Friberg executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Apr 21, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Rashmi Ramchandani executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2025 | Oct 16, 2026 | Not yet signed | Not yet signed | Ian T. Clark seat on BIOMARIN PHARMACEUTICAL INC, effective 2025-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2025 | Oct 16, 2026 | Not yet signed | Not yet signed | Timothy P. Walbert seat on BIOMARIN PHARMACEUTICAL INC, effective 2025-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2025 | Oct 16, 2026 | Not yet signed | Not yet signed | Compensation; Nominating and Governance committee of BIOMARIN PHARMACEUTICAL INC, effective 2025-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2025 | Oct 16, 2026 | Not yet signed | Not yet signed | Timothy P. Walbert member of Compensation; Nominating and Governance, effective 2025-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2023 | Oct 16, 2026 | Not yet signed | Not yet signed | Adrian Hardy seat on BIOMARIN PHARMACEUTICAL INC, effective 2023-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2023 | Oct 16, 2026 | Not yet signed | Not yet signed | Athena Countouriotis seat on BIOMARIN PHARMACEUTICAL INC, effective 2023-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2023 | Oct 16, 2026 | Not yet signed | Not yet signed | Barbara W. Bodem seat on BIOMARIN PHARMACEUTICAL INC, effective 2023-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2023 | Oct 16, 2026 | Not yet signed | Not yet signed | Mark Enyedy seat on BIOMARIN PHARMACEUTICAL INC, effective 2023-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2023 | Oct 16, 2026 | Not yet signed | Not yet signed | Barbara W. Bodem member of Audit, effective 2023-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2021 | Oct 16, 2026 | Not yet signed | Not yet signed | Maykin Ho seat on BIOMARIN PHARMACEUTICAL INC, effective 2021-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2019 | Oct 16, 2026 | Not yet signed | Not yet signed | Elizabeth McKee Anderson seat on BIOMARIN PHARMACEUTICAL INC, effective 2019-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2019 | Oct 16, 2026 | Not yet signed | Not yet signed | Compensation · Chair committee of BIOMARIN PHARMACEUTICAL INC, effective 2019-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2019 | Oct 16, 2026 | Not yet signed | Not yet signed | Elizabeth McKee Anderson member of Compensation · Chair, effective 2019-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2017 | Oct 16, 2026 | Not yet signed | Not yet signed | Robert J. Hombach seat on BIOMARIN PHARMACEUTICAL INC, effective 2017-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2017 | Oct 16, 2026 | Not yet signed | Not yet signed | Audit · Chair committee of BIOMARIN PHARMACEUTICAL INC, effective 2017-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2017 | Oct 16, 2026 | Not yet signed | Not yet signed | Robert J. Hombach member of Audit · Chair, effective 2017-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2016 | Oct 16, 2026 | Not yet signed | Not yet signed | Willard Dere seat on BIOMARIN PHARMACEUTICAL INC, effective 2016-01-01. |
Access, rights, and the public-role doctrine
Facts are open. Rights travel with every Claim and every Evidence record, so an agent sees the same terms whichever format it reads.
| Capability | Access | Agents |
|---|---|---|
| Alpha Disclosure sample | public | human process |
| Alpha public website | public | retrievable now |
| Alpha Standard, methodology, and research | public | retrievable now |
| Alpha Profiles (public executive and company records) | public | retrievable now |
| Public HTTP endpoints described by OpenAPI 3.1 | public | retrievable now |
| Alpha MCP public discovery and read-only capabilities | public | retrievable now |
| Alpha AI Readiness Eval | public | human process |
| Alpha Platform | approved access | requires approved access |
| Alpha API (authenticated operations) | approved access | requires approved access |
| Alpha MCP premium capabilities | approved access | requires approved access |
| Alpha Evals and verified assessments | custom | human process |
| Alpha Council membership | custom | human process |
| Alpha Institute education, workshops, and coaching | custom | human process |
| Governance diagnostics and institutional advisory | custom | human process |
Record limitations. Every representation states these in the same words; nothing is inferred as zero.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
"rights": {
"public_retrieval": "allowed",
"agent_retrieval": "allowed",
"redistribution": "not_granted",
"model_training": "not_granted",
"commercial_use": "not_specified",
"relationship_pathfinding": "not_granted",
"direct_contact": "not_granted"
}
"evidence_rights": {
"evidence_records": 13,
"redistribution_allowed": 0,
"restricted_or_unknown": 13,
"classified_unknown": 13
}"data_subject": {
"basis": "public_record",
"entity": "alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8",
"identity_ownership": "unclaimed",
"rights": {
"public_retrieval": "allowed",
"agent_retrieval": "allowed",
"redistribution": "not_granted",
"model_training": "not_granted",
"commercial_use": "not_specified",
"relationship_pathfinding": "not_granted",
"direct_contact": "not_granted"
},
"requests": "https://www.alpha.ac/contact"
}How agents find this
OpenThe page head and every response carry rel="alternate" links and the Registry's Link header. The list below is generated from the same list the server emits.
/.well-known/ai-catalog.jsonAlpha Agentic Resource Discovery manifest/.well-known/api-catalogapi-catalog/.well-known/webmcp.jsonAlpha WebMCP tool discovery/openapi.jsonAlpha Governance Public Intelligence API (OpenAPI 3.1)/apiAlpha Intelligence API/developersAlpha Governance Developer Platform/docs/trustcheck-receipts-v01.mdTrustCheck and Governance Receipts v0.1 test preview/docs/apiAlpha service documentation/llms.txtAlpha service docs for AI agents/agents.mdAlpha agent instructions (when to use Alpha)/api-versioning.mdAlpha public API versioning and deprecation policy/.well-known/agent-skills/index.jsonAgent Skills Index/products/accessAlpha Access and Availability/api/public/product-accessAlpha Product Access and Availability JSON/api/public/auth-capabilitiesAlpha Authentication Capabilities JSON/peopleAlpha Executive Profiles/companiesAlpha Company Profiles/people/readinessAlpha Profile Coverage and Agent Readiness/api/public/profile-readinessAlpha Public Profile Readiness JSON/api/public/profiles/steven-wolfe-pereiraAlpha Public Profile JSON Example/.well-known/agent-card.jsonA2A Agent Card/.well-known/mcp/server-card.jsonMCP Server Card/.well-known/openid-configurationOpenID Configuration/.well-known/oauth-protected-resourceOAuth Protected Resource/.well-known/oauth-authorization-serverOAuth Authorization Server (agent_auth)/.well-known/agent-registrationAgent Registration/.well-known/http-message-signatures-directoryhttp-message-signatures-directory/.well-known/jwks-rotationJWKS Rotation Policy/auth.mdAgent Authentication/llms.txtSite overview for AI agents/sitemap.xmlsitemap/api/public/agent-readinessAgent Readiness Status/api/public/company-report/osw-market-dataOSW Market Data Verification
Record map and assertion states
| Section | Anchor | Resource | State | Claims |
|---|---|---|---|---|
| Identity | #c-subject | /identity | Published | 0 |
| Corporate structure | - | /corporate_structure | Not reviewed | - |
| Board | #c-board | /board | Published | 10 |
| Committees | #c-committees | /committees | Published | 10 |
| Leadership | #c-leadership | /leadership | Published | 10 |
| Ownership | #c-control | /ownership | Not reviewed | 0 |
| Financials | #c-financials | /financials | Not reviewed | 1 |
| Capital structure | - | /capital_structure | Published | - |
| Compensation | #c-comp | /compensation | Not reviewed | 0 |
| Governance | #c-governance | /governance | Not reviewed | 0 |
| Shareholder governance | - | /shareholder_governance | Not reviewed | - |
| Audit | - | /audit | Not reviewed | - |
| Legal | #c-legal | /legal | Not reviewed | 0 |
| Risk | #c-risk | /risk | Not reviewed | 0 |
| Cyber | - | /cyber | Not reviewed | - |
| AI governance | #c-ai | /ai_governance | Not reviewed | 0 |
| Agent governance | #c-authority | /agent_governance | Restricted | 0 |
| Markets external | - | /markets_external | Not reviewed | - |
| Events | #c-history | /events | Published | 25 |
| Relationships | #c-links | /relationships | Published | 20 |
| Assessments | #c-monitor | /assessments | Published | 0 |
| Evidence | #c-evidence | /evidence | Published | 13 |
- corroboratedTwo or more independent sources agree
- source_reportedOne cited source states it
- alpha_inferenceAlpha's conclusion, with reasoning
- not_disclosedSearched, nothing found. Never rendered as false
- not_reviewedNot yet searched
- not_registeredNo authority registered with Alpha



